Table 1.
Characteristics of two groups of COVID-19 patients defined according to their hospitalisation either in a respiratory ward (n = 61) or in an intensive care unit (n = 43). (n = 104; mean ± SEM); ICU: Intensive Care Unit, BMI: Body Mass Index; PaO2: arterial pressure in oxygen; CT-Scan: percentage of lung ground glass opacity and area with more condensed aspect. HT: Hypertension; COPD: Chronic Obstructive Pulmonary Disease.
| Non-ICU | ICU | Adjusted p-Value |
|||||
|---|---|---|---|---|---|---|---|
| Mean | ± | SEM | Mean | ± | SEM | ||
| Sex (F/M) | 26/35 | 18/25 | |||||
| Survival (% [Surv-deceased]) | 98.4% [60/1] | 37.2% [16/27] | <0.001 | ||||
| Nb. of comorbidities: | |||||||
| 0 (n (%)) | 39 (63.9%) | 15 (34.9%) | <0.01 | ||||
| 1 (n (%)) | 12 (19.7%) | 16 (37.2%) | <0.05 | ||||
| >=2 (n (%)) | 10 (16.4%) | 12 (27.9%) | 0.16 | ||||
| Nature of comorbidities: | |||||||
| Diabetes (n (%)) | 9 (15%) | 13 (30%) | 0.06 | ||||
| HT (n (%)) | 16 (26%) | 15 (35%) | 0.35 | ||||
| COPD (n (%)) | 2 (3%) | 4 (9%) | 0.20 | ||||
| Renal disease (n (%)) | 1 (2%) | 2 (5%) | 0.37 | ||||
| Cancer (n (%)) | 4 (7%) | 7 (16%) | 0.11 | ||||
| Age (year) | 66.1 | ± | 8.51 | 71.6 | ± | 10.68 | 0.31 |
| BMI (kg/m²) | 26.4 | ± | 3.66 | 26.8 | ± | 4.12 | 0.31 |
| PaO2 (mmHg) | 59.9 | ± | 7.84 | 53.3 | ± | 8.21 | <0.01 |
| CRP (mg/L) | 92.3 | ± | 10.58 | 138.1 | ± | 20.98 | 0.09 |
| CT-Scan (%) | 33.3 | ± | 4.68 | 55.3 | ± | 8.22 | <0.01 |
| Lymphocytes (abs. x10/µL) | 1.57 | ± | 0.17 | 0.86 | ± | 0.13 | <0.001 |
| Fibrinogen (mg/dL) | 570.4 | ± | 73.54 | 588.5 | ± | 87.59 | 0.99 |
| D.Dimer (ng/mL) | 2192 | ± | 286.02 | 3860 | ± | 560.52 | 0.31 |
| Creatinine (mg/dL) | 1.41 | ± | 0.18 | 1.38 | ± | 0.21 | 0.64 |
| Ferritin (ng/mL) | 546.0 | ± | 55.65 | 917.1 | ± | 152.55 | <0.05 |
| LDH (UI/I) | 421.9 | ± | 54.75 | 528.6 | ± | 79.23 | 0.06 |
| Procalcitonin (ng/mL) | 0.32 | ± | 0.04 | 1.01 | ± | 0.63 | 0.31 |